MENLO PARK, Calif. (AP) _ Pacific Biosciences of California Inc. (PACB) on Thursday reported a loss of $22 million in its third quarter.
On a per-share basis, the Menlo Park, California-based company said it had a loss of 19 cents.
The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 20 cents per share.
The maker of genetic analysis technology posted revenue of $23.5 million in the period.
In the final minutes of trading on Thursday, the company's shares hit $4.03. A year ago, they were trading at $8.28.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PACB at https://www.zacks.com/ap/PACB